genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Ophthalmic diseases
Genome Editing
Prime Editors, Delivered by Virus-Like Particles, Partially Restore Vision in Blind Mice
News
Molecular Pathway Helps Determine Age-Related Macular Degeneration Type
Featured
Human Glia Reprogrammed into Neuron-Generating Cells
Drug Discovery
Graphite Erased: LENZ to Merge with Gene Editing Therapy Developer
Genome Editing
Prime Medicine Presents First In Vivo Prime Editing Data to Treat Ophthalmological Diseases
Drug Discovery
Vitreoretinal Diseases May Find Treatment in Exosome-Loaded Microcapsules
Drug Discovery
As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug
GEN Edge
StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
Drug Discovery
On Your Mark: ALSA Ventures Lifts Early-Stage European Biotechs to Jockey Out of the Gate
GEN Edge
StockWatch: Short Seller Briefly Dents Apellis Shares
1
2
3
4
...
44
Page 3 of 44
Scroll Up
Scroll Up
